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Abstract
The increase of death rate, associated with infectious diseases, is directly linked to the
bacteria that have multiple resistance to antibiotics. The lack of efficient medical treat-
ment is the main cause of this problem. The synthesis of new antibacterial agents,
through various methods, is, for sure, an emergency medical issue. Recent research
focuses more and more on the synthesis of complexes of the transitional metals with
ligands of Schiff-base type, as a result of the biological properties which they have. This
article presents the synthesis of several complexes with base Schiff ligands, derived from
4-aminoantipyrine and in vitro research of their antibacterial activities. The new com-
pounds were tested for their in vitro antibacterial activity against Staphylococcus aureus
var. Oxford 6538, Klebsiella pneumoniae ATCC 100131, Escherichia coli ATCC 10536, and
Pseudomonas aeruginosa ATCC 9027 strains. Based on the “in vitro” studies, we can say
that ten of the complexes synthetized can be successfully used instead of streptomycin,
where there is resistance to this antibiotic.
Keywords: 4-aminoantipyrine, Schiff bases, metal complexes, antibacterial agents,
streptomycin
1. Introduction
The synthesis of new antibacterial agents, through various methods, is, for sure, an emergency
medical issue [1–3]. Schiff bases are important precursors for the synthesis of some bioactive
compounds [4, 5]. Schiff bases have received considerable attention since the discovery of their
antibacterial [6, 7], antifungal [8], anti-HIV [9, 10], anti-inflammatory [11], anticonvulsant
[12, 13], antiviral [14], and anticancer properties [15–17]. The presence of the inimical grouping
in these organic ligands plays an important part in manifesting these biological characteristics
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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[18–20]. Schiff bases can be regarded as promising antimicrobial agents. For example,
N-(salicylidene)-2-hydroxyaniline proved efficiency against Mycobacterium tuberculosis H37Rv,
exhibiting an MIC value of 8μg/mL [21]. The 5-chloro-salicylaldehyde-Shiff base derivatives are
efficient against Pseudomonas fluorescence (MIC=2.5–5.2μg/mL), Escherichia coli (MIC=1.6–5.7μg/mL),
Bacillus subtilis (MIC=1.8μg/mL), and Staphylococcus aureus (MIC=1.6 and 3.1μg/mL), respec-
tively, while the MIC values for the reference drug kanamycin against the same bacterial strains
were 3.9μg/mL [22]. Some of the isatin-derived Schiff bases have shown antibacterial activity
against Escherichia coli NCTC 10418 (MIC=2.4μg/mL), Vibrio cholerae non-01(MIC=0.3μg/mL),
Enterococcus faecalis (MIC=1.2μg/mL), and Proteus shigelloides (MIC=4.9 μg/mL). The MIC values
for the reference drug sulfamethoxazole against the same bacterial strain were in the range
of 312–5000μg/mL. Therefore, these compounds were proven to be 1040-, 1040-, 4160-, and
1020-fold more potent than sulfamethoxazole [23, 24]. The studies run on the Schiff bases,
derived from the isoniazid have allowed to identify a compound which has turned out to have
a therapeutical effectiveness and safety, that is, 4000 times higher than that of isoniazid [25].
Themorpholine-derived Schiff bases was effective against Staphylococcus aureus (MIC=20μg/mL),
Micrococcus luteus (MIC=32μg/mL), Streptococcus epidermidis (MIC=17μg/mL), Bacillus cereus
(MIC=21μg/mL), and Escherichia coli (MIC=16μg/mL).
Schiff bases with a 2,4-dichloro-5-fluorophenyl moiety completely inhibited the growth of Staph-
ylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. MIC values for
these compounds varied from 6.3 to 12.5μg /mL, which are comparable to those obtained for the
reference drug ciprofloxacin [26]. Lately, within the last couple of years, a special attention has
been paid to the chemistry of the metal complexes of the Schiff bases. This is due to the chemical
stability of the complexes as well as to the possibility of using them in the most varied fields. To a
great extent, remarkable successes, in this field, have been obtained due to the various synthesis
methods of the complexes. Recent research focuses more and more on the synthesis of complexes
of the transitional metals with ligands of Schiff-base type, as a result of the biological properties
which they have. In many cases, the conclusion has been that, through the coordination of the
Schiff bases, to the metal ions, which are present in the biological systems, the biological activity of
the respective Schiff base increases. A large number of Schiff bases and the corresponding metal
complexes have proven antibacterian, antifungal, antitumor, and antileukemia activity [27–29].
Ever since it was synthesized [30], antipyrine (1-fenil-2,3-dimetil-5-pirazolona) has enjoyed a lot of
attention due to its analgesic and antipyretic properties. The discovery of these properties has
allowed for deeper research on antipyrine and its derivatives. Thus, 4-amino-2,3-dimethyl-1-
phenyl-3-pyrazolin-5-one (4-aminoantipyrine) was discovered, a derivative with analgesic action,
antipyretic, anti-inflammatory, antibacterian, and antineoplastic [31, 32]. The derivatives of 4-
aminoantipyrine are used in the synthesis of azo-colorant, in analytical chemistry for spectropho-
tometric determination of metal ions [33], in pharmacology, as an effective antitumor [34], analge-
sic [35], antiviral [36], anti-inflammatory [37], anticancer [38], and antimicrobial drugs [39–42].
Lately, the research has been conducted in order to get metal complexes with a wide range of
biological activities and with the lowest level of toxicity. In this work, the synthesis of some
complexes with base Schiff ligands is presented, derived from 4-aminoantipyrine and in vitro
research of their antibacterial activities.
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2. Experimental
2.1. Metal complexes with aminoantipyrine Schiff bases: structure and methods of
synthesis
Complexes of Cu(II), Co(II), Ni(II), Zn(II), Mn(II), VO(II), and Fe(III) were prepared by direct
reaction between Schiff base ligand and the corresponding metal salts.
The next Schiff bases were synthesized:
• 1-phenyl-2,3-dimethyl-4-(N- acetoacetanilide)-3-pyrazolin-5-one (HL1)
• 1,5-dimethyl-2-phenyl-4-(1-(pyridin-2-yl)ethylideneamino)-1H-pyrazol-3(2H)-one (HL2)
• 5-nitro-salicylidene-4-aminoantipyrine (HL3)
• 4-((E)-4-((E)-(4-chlorophenyl)diazenyl)-2-hydroxybenzylideneamino)-1,5-dimethyl-2-phenyl-
1H-pyrazol-3(2H)-one (HL4)
• 1-phenyl-2,3-dimethyl-4-(N-imidazole-2-carboxaldehyd)-3-pyrazolin-5-one (HL5)
• 4-(2-pyrrolylmethylideneamino)antipyrine (HL6)
• 4[(benzylidene)amino]antipyrine (HL7)
• 4[(cinnamalidene)amino]antipyrine (HL8)
• 4[(2-chlorobenzylidene)amino]antipyrine (HL9)
• 4-[(furan-2-ylmethylene)amino]-1,2-dihydro-1,5-dimethyl-2-phenyl-3Hpyrazol-3-one(HL10)
• 1-phenyl-2,3–dimethyl-4-(2-hydroxy-5-nitro-benzylideneamino)-3-pyrazolin-5-one (HL11)
• salicylidene-4-aminoantipyrine (HL12)
• salicylidene-4-aminoantipyrinyl-2-amino-3-hydroxypyridine (HL13)
• napthylidene-4-aminoantipyrine (HL14)
• 5-[(E)-[(3Z)-3-[2-[(Z)-[4-[(E)-(3-hydroxy-4-nitro-phenyl)methyleneamino]-1,5-dimethyl-2-
phenyl-pyrazol-3-ylidene]amino]phenyl]imino-1,5-dimethyl-2-phenyl-pyrazol-4-yl]
iminomethyl]-2-nitro-phenol (HL15)
• 4-[(E)-[(3Z)-3-[2-[(Z)-[4-[(E)-(4-hydroxy-3-methoxy-phenyl)methyleneamino]-1,5-
dimethyl-2-phenyl-pyrazol-3-ylidene]amino]phenyl]imino-1,5-dimethyl-2-phenyl-
pyrazol-4-yl]iminomethyl]-2-methoxy-phenol (HL16)
• 3-salicylideneacetylacetone-2,4-di(imino-40-antipyrinyl)pentane (HL17)
• 2,6-diformyl-4-methylphenol bis(4-amino-3-antipyrine) (HL18)
• 4,40-(1E,10E)-(1,1
0
-(pyridine-2,6-diyl)bis(ethan-1-yl-1-ylidene))bis(azan-1-yl-1-ylidene) bis
(1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one) (HL19)
• 3(30-hydroxy-40-nitrobenzalidene)-2,4-di(imino-40-antipyrinyl)pentane (HL20)
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2.1.1. Synthesis of the complexes with HL1–5 ligands
The metal complexes with these Schiff bases are obtained by adding a methanolic or ethanolic
ligand solution to a solution of metal salt, in a molar ratio L:M=2:1 [43, 44] or 1:1 [45–47]. The
mixture of reaction is refluxed for 2–5h or stirring for 12h. The precipitate is obtained that is
filtered, washed with ether, methanol or ethanol, and dried in vacuo (Figures 1–4).
M2+
M2+ = Cu2+, Ni2+, Co2+, Mn2+, Zn2+,Cd2+, Hg2+, VO2+, UO2
2+, ZrO2+
, 
Figure 1. Scheme of synthesis of complexes with ligand HL1.
n Cl MCl2 / CrCl3
n = 3 for M = Cr(III) and n = 2 for M = Cu(II), Co(II), Mn(II), Ni(II)
Figure 2. Scheme of synthesis of complexes with ligand HL2.
MCl
2
M = Cu2+, Co2+, Ni2+, Zn2+
CH
3
CH
2
OH
CH
3
CH
2
OH
refluxed 3h
refluxed 3h
Figure 3. Scheme of synthesis of complexes with ligand HL4.
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2.1.2. Synthesis of the complexes with ligands HL6–11 and various co-ligands
The metal complexes with ligands base Schiff HL6–11 are obtained through three methods:
Method 1. Previously, the complex combination with the Schiff base is obtained to which the co-
ligand is added(α-picoline, β-picoline, γ-picoline, n-propylamine). After the complete precipi-
tation, the solid compound is obtained that is filtered, washed with ether, and dried in the
exicator (Figure 5) [48].
Method 2. The mixture of reaction which contains the alcoholic ligand solutions (the Schiff base
and the co-ligand) and the alcoholic solution of metal salt is refluxed for 6–8h. After the concen-
tration of the solution to a third of its volume, on the water bath, a precipitate is obtained which
is filtered, washed with alcohol, and dried in vacuo (Figure 6) [49]; (Figure 7) [50, 51].
M = Cu2+, Co2+, Ni2+, Zn2+
MCl
2
CH
3
OH
CH
3
OH
stirred 3h
refluxed 6h
Figure 4. Scheme of synthesis of complexes with ligand HL5.
X
2
X = Cl, Br
X = NO
3
, ClO
4
+ CuX
2
+ CuX
2
+ Cu(CH
3
COO)
2
+ R
R = Py, Pic, Pic, Pic, n-PrNH
2
X
2
2
Figure 5. Scheme of synthesis of complexes with ligand HL6.
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Method 3. By adding an ethanolic solution of Schiff base to a metal salt solution, in a molar ratio
1:1, a mixture is obtained which is refluxed for 3–8h. An ethanol solution of co-ligand (amino
acids; 1,10-phenanthroline; 2,20- bipyridine; etc.) is added in the reaction environment, and the
reflux is kept going on for another 1–3h. The precipitate is obtained which is filtered, washed
in ether, and dried in vacuo (Figure 7) [52, 53]; (Figure 8) [54].
2.1.3. Synthesis of the complexes with ligands HL10, 12–14 and various aromatic amine
The metal complexes with these Schiff bases are obtained through refluxing, lasting for 3–4h of
a mixture that contains the metal salt dissolved in ethanol and the ligand dissolved in the same
solvent. The ligand can be previously obtained through two different methods (Figure 9) [55],
respectively (Figure 10) [53, 56–58].
2.1.4. Synthesis of the complexes with ligands HL15 and HL16
The metal complexes with ligands Schiff bases HL15 and HL16 are obtained by treating a ligand
solution with a solution of metal salt, in a molar ratio L:M=1:1. The mixture is refluxed for 5–6h.
After the concentration of the solution to a third of its volume, on the water bath, a precipitate is
obtained which is filtered, washed with ether, and dried in vacuo (Figure 11) [59, 60].
2.1.5. Synthesis of the complexes with ligands HL17–20
The metal complexes with Schiff base ligands HL17–20 are obtained through treating a solution
that contains the ligand dissolved in ethanol or acetonitrile with the solution of metal salt, in a
molar ratio of L:M=1:1. The mixture is refluxed for 5–6h (Figures 12, 13) [61–64] or, in other
cases, even 12h (Figure 14) [45]. The precipitation begins immediately or after the concentration
of the solution to a third of its volume, on a water bath. The precipitate is obtained which is
filtered, washed with ether, and dried in vacuo.
+
R = , ,
+ VOSO
4
+
stirred
refluxed 2h
SO
4
Figure 6. Scheme of synthesis of complexes with ligands HL7–9.
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KOH
R = H, CH
3
, (CH
3
)
2
CH
M = Cu2+, Co2+, Ni2+, Zn2+
refluxed 2 h
NO
2
MCl
2 
/ FeCl
3
NO
2NO2
Cl
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CH
3
CH
2
OH
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M = Cu2+, Co2+, Ni2+, Zn2+
MCl
2
 / FeCl
3
or
CH
3
CH
2
OH
refluxed 3-6h 
MCl
2
Cl
2
M = Cu2+, Co2+, Ni2+, Zn2+, Mn2+
CH
3
CH
2
OH
CH
3
CH
2
OH
refluxed 
refluxed 3 h
Figure 7. Scheme of synthesis of complexes with ligand HL10.
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The study methods used to describe the complexes were as follows: the basic chemical analy-
sis, spectrometry IR, UV-VIS, EPR, the thermogravimetric analysis, the magnetic susceptibility,
and the molar electric conductibility. The complexes synthetized were tested from the point of
view of the antibacterian activity; the obtained results were presented in the respective papers.
2.2. New compounds: structure and antibacterial activity
2.2.1. Structure and synthesis of the compounds 1–28
With a view to obtaining new compounds with significant antibacterian activity, we have
synthesized and characterized a series of complexes of Cu(II), Ni(II), Mn(II), and V(IV) with
ligands Schiff bases, derived from 4-aminoantipyrine.
In this regard, we have synthesized four ligands, with chromophore groups ONO, respectively,
ON, and different volumes of the aldehyde which is a part of Schiff base: 1-phenyl-2,3-dimethyl-
4-(N-3-formyl-6-methyl-chromone)-3-pyrazolin-5-one (HL21); 1-phenyl-2,3-dimethyl-4-(N-2-
hydroxy-4-methoxy-benzaldehyde)-3-pyrazolin-5-one (HL22); 1-phenyl-2,3-dimethyl-4-(1H-
indole-3-carboxaldehyde)-3-pyrazolin-5-one (HL23); 1-phenyl-2,3-dimethyl-4-(N-pyridoxal
hydrochloride)-3-pyrazolin-5-one (HL24) as well as their complex combinations with transitional
metals: Cu2+, Ni2+, Mn2+, VO2+ (28 metal complexes).
OAc
OAc or
AcO
AcO
/
NO
2
NO
2
NO
2
Cu(CH
3
COO)
2 
 / Co(CH
3
COO)
2
OHC
refluxed 3h
refluxed 2-3h
NO
2
NO
2
NO
2
CH
3
OH
CH
3
OH
Figure 8. Scheme of synthesis of complexes with ligand HL11.
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X = H, Cl, CH
3
, NO
2
CuCl
2
stirred 3h
CH
3
CH
2
OH
CH
3
CH
2
OH
CH
3
CH
2
OH
refluxed 6h 
refluxed 
Figure 9. Scheme of synthesis of complexes with ligand HL12.
X = H, p-NO
2
, p-OH
CH
3
CH
2
OH
Cu(CH
3
COO)
2
CH
3
CH
2
OH
stirred 3h
Y = CH
3
COO
X
refluxed 6h 
X
X
Figure 10. Scheme of synthesis of complexes with ligand HL10.
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The study methods used to characterize the metal complexes were as follows: elemental
analysis, the thermogravimetric analysis, IR, UV-Vis, EPR spectroscopy, the molar electric
conductibility, the magnetic susceptibility, and the X-ray diffraction.
2.2.1.1. Synthesis of the complexes with ligand HL21
Ligand C24H25N3O4, ðHL
21Þ
Ethanolic solution of 3-formyl-6-methyl-chromone (1mmol) and 4-amino-2,3-dimethyl-1-phenyl-
3-pyrazolin-5-one (1mmol) was stirred at room temperature, then refluxed for 2h, and kept at
HL15: R = OH; M= Cu2+, Co2+, Mn2+,Ni2+, Zn2+, Cd2+, Hg2+, VO2+; X = 0; Y = Cl
HL16: R = OCH
3
; M= Cu2+, Co2+, Ni2+, Zn2+ ; X = Cl; Y = 0
Y
2
OHC
CH
3
OH/CH
3
CH
2
OH
MCl2
stirred 1- 2h
CH
3
OH/CH
3
CH
2
OH
refluxed 36h
refluxed 5-6h
CH
3
OH/CH
3
CH
2
OH/KNO
3
Figure 11. Scheme of synthesis of complexes with ligands HL15 and HL16.
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12
3
1
1
2
2 2 1
3
3 3
MCl
2
VOSO
4
HL17: R
1
 = OH, R
2
 = o, R
3
 = o; M = Cu2+, Co2+, Ni2+, Zn2+
HL20: R
1
 = o, R
2
 = OH, R
3
 = NO
2
; M = Cu2+, Ni2+, Zn2+
SO
4
CH
3
CH
2
OH / K
2
CO
3
Cl
2
Figure 12. Scheme of synthesis of complexes with ligands HL17 and HL20.
MCl
2
refluxed 3h
CH
3
CH
2
OH
M = Cu
2+
, Co
2+
, Ni
2+
, Zn
2+
N
N
N
CH3
CH3O
OHN
N
N
CH3
CH3 O
CH3
N
N
CH3O
M
NO
M
ON
N
CH3
NCH3
Cl
Cl
Cl
CH3
CH3
+
Figure 13. Scheme of synthesis of complexes with ligand HL18.
MCl
2
 / CrCl
3
n Cl 
n = 2 for M = Cr(III) and n = 1 for M = Cu(II), Co(II), Mn(II), Ni(II)
Figure 14. Scheme of synthesis of complexes with ligand HL19.
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4C for 2days. The resulting precipitate of intense yellow color was filtered, washed with
methanol, and dried. Yellow single crystals suitable for structure determination were obtained
from methanolic solution upon slow evaporation at room temperature [65].
Complexes 1–3 and 5–9were prepared by direct reaction between the ligand and the corresponding
metal salts, while complex 4 was prepared by the metathetical displacement of the acetate ion,
in Cu(OAc)2H2O, by the thiocyanate ion [65] (Figures 15, 16).
½Cu2L
21Cl2 (1)
To CuCl22H2O (2mmol) dissolved in aqueous/ethanol solution (1:2v/v) was added ligand
HL21 (2mmol) dissolved in hot ethanol and refluxing for 2h. The green-brown precipitate,
which separated on cooling, was filtered, washed with hot water, ethanol followed by ether,
and dried in vacuo.
½CuL21ðNO3Þ (2)
Complex 2 was prepared similarly, using Cu(NO3)23H2O (2mmol). Green solid.
½CuL21ðOAcÞCH3OH (3)
Complex 3 was prepared similarly, using Cu(OAc)2H2O (2mmol). Brown solid, X-ray quality
single crystals were obtained.
½CuL21ðSCNÞ (4)
For the synthesis of complex 4, the acetate complex was first prepared and the acetate ion was
then displaced by thiocyanate ion by using KSCN (2mmol). Dark-green solid.
Figure 15. X-ray molecular structure of ligand HL21 and complex 3.
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½CuL21ðH2OÞðClO4Þ (5)
Complex 5was prepared similarly, using Cu(ClO4)26H2O (2mmol). The mixture was stirred at
room temperature for 1h, when a dark-green precipitate appeared immediately.
½Cu2ðL
21Þ2ðH2OÞ4SO4 (6)
Complex 6 was prepared similarly, using CuSO45H2O (2mmol). The mixture was stirred at
reflux temperature for 4h, when appeared a dark-green precipitate.
1      6
2-4 5
89,7
SO
4
X = NO
3
- , OAc -, SCN-
ClO
4
M = Ni2+, Mn2+
Figure 16. Proposed structures of the metal complexes 1–9.
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½NiðL21Þ2 (7)
Complex 7 was prepared similarly, using NiCl26H2O (2mmol). Green to yellow solid.
½VOðL21Þ2 (8)
Complex 8 was prepared similarly, using VOSO42H2O (2mmol). Brown solid.
½MnðL21Þ2 (9)
Complex 9 was prepared similarly, using Mn(ClO4)26H2O (2mmol). Orange solid.
2.2.1.2. Synthesis of the complexes with ligand HL22
Ligand C19H19N3O3, ðHL
22Þ
The ligand HL22 was synthesized by refluxing equimolar amounts of 4-amino-2,3-dimethyl-1-
phenyl-3-pyrazolin-5-one and 2-hydroxy-4-methoxy-benzaldehyde in ethanol according to the
experimental protocol described in Ref. [66].
Complexes 10–12, 14, and 15 were prepared by the direct reaction between the ligand and the
corresponding metal salts. Complex 13 was obtained by refluxing a mixture of CuCl22H2O
and 1-phenyl-2,3-dimethyl-4-(N-2-hydroxy-4-methoxy-benzaldehyde)-3-pyrazolin-5-one with
the addition of KSCN (Figures 17, 18) [66].
½CuL22ClðH2OÞ (10)
An ethanol solution of CuCl22H2O (2mmol, 15mL aqueous/ethanol 1:2 v/v) was added
dropwise to a stirred ethanol solution of the Schiff base ligand HL22 (2mmol, 15mL). The
resulting solution was stirring for 3h at room temperature. The green-brown colored solid
was filtered, washed with hot water, ethanol followed by ether, and dried in vacuo.
Figure 17. X-ray molecular structure of ligand HL22 and complex 12.
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½CuL22ðNO3ÞðH2OÞ2 (11)
Complex 11 was prepared similarly, using Cu(NO3)23H2O (2mmol). Dark-green solid.
½CuðL22Þ2 (12)
Complex 12was prepared similarly, using Cu(OAc)2H2O (2mmol). Brown solid, X-ray quality
single crystals were obtained.
½CuL22ðSCNÞðH2OÞ2 (13)
For the synthesis of complex 13, the chloride complex was first prepared and chloride ion was
then displaced by thiocyanate ion by using KSCN (2mmol). The green colored solid, which
separated on cooling, were filtered, washed with hot water, ethanol followed by ether and
dried in vacuo.
½CuL22ðClO4ÞðH2OÞ2 (14)
Complex 14 was prepared similarly, using Cu(ClO4)26H2O (2mmol). Green solid.
10    15
21 11, 13, 14
SO
4
X = NO
3
- , SCN -, ClO
4
-
Figure 18. Proposed structures of the metal complexes 10–15.
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½Cu2ðL
22Þ2ðH2OÞ4 SO4 (15)
Complex 15 was prepared similarly, using CuSO45H2O (2mmol). Dark-green solid.
2.2.1.3. Synthesis of the complexes with ligand HL23
Ligand C20H18N4O, ðHL
23Þ
The ligand HL23 was synthesized by refluxing equimolar amounts of 4-amino-2,3-dimethyl-1-
phenyl-3-pyrazolin-5-one and indole-3-carboxaldehyde in methanol according to the experi-
mental protocol described in Ref. [67].
Complexes 16–21 were prepared by direct reaction between the ligand and the corresponding
metal salts (Figures 19, 20) [67].
½CuðL23Þ2Cl2 (16)
To a stirred solution of CuCl22H2O (1mmol) in ethanol (15mL) was added a solution of ligand
HL23 (1mmol) in ethanol (15mL). The mixture was stirred at reflux temperature for 2h. The
resulting precipitate of green-brown color was filtered, washed with ethanol, and dried.
½CuðL23Þ2 ðNO3Þ2 (17)
Complex 17 was prepared similarly, using Cu(NO3)23H2O (1mmol). Brown solid.
½CuðL23Þ2ðOAcÞ2 (18)
Figure 19. X-ray molecular structure of ligand HL23.
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Complex 18 was prepared similarly, using Cu(OAc)2H2O (1mmol). Dark-green solid.
½CuðL23Þ2ðH2OÞ2 SO4 (19)
Complex 15 was prepared similarly, using CuSO45H2O (1mmol). Green solid.
½VOðL23Þ2ðH2OÞ SO4 (20)
Complex 20 was prepared in a similarly, using VOSO42H2O. Green solid.
½NiðL23Þ2ðH2OÞ2Cl2 (21)
Complex 21 was prepared in a similarly, using NiCl26H2O. Dark-green solid.
18 19
20  21
X = OAc -
SO
4
2
2
SO
4
Cl
2
2
2
16 17
(NO
3
)
2
Figure 20. Proposed structures of the metal complexes 16–21.
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2.2.1.4. Synthesis of the complexes with ligand HL24
Ligand C19H20N4O3, ðHL
24Þ
The ligand HL24 was synthesized by refluxing equimolar amounts of 4-amino-2,3-dimethyl-1-
phenyl-3-pyrazolin-5-one and pyridoxal hydrochloride in methanol according to the experi-
mental protocol described in Ref. [68].
Complexes 22–28 were prepared by direct reaction between the ligand and the corresponding
metal salts (Figures 21, 22) [68].
½CuL24Cl2 (22)
To a hot solution ofHL24 (1mmol) inmethanol was added a hot solution of CuCl22H2O (2mmol) in
aqueous/methanol (1:2 v/v), and the mixture was stirred at reflux temperature for 4h. Brown solid.
½CuL24ðH2OÞ2 NO3  2:25H2O (23)
Complex 23 was prepared similarly, using Cu(NO3)23H2O (1mmol). The mixture was stirred
at room temperature for 7h. Brown solid, X-ray quality single crystals were obtained.
½CuðL24ÞðOAcÞðH2OÞ (24)
Complex 24was prepared similarly, using Cu(OAc)2H2O (2mmol). The mixture was stirred at
reflux temperature for 4h. Green-brown solid.
Figure 21. X-ray molecular structure of ligand HL24 and complex 23.
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½CuL24ðH2OÞ2 ClO4 (25)
Complex 25 was prepared similarly, using Cu(ClO4)26H2O (2mmol). The mixture was stirred
at reflux temperature for 5h. Brown solid.
27  28
SCN
22 24
52 26
2
ClO
4
2
2
2
Figure 22. Proposed structures of the metal complexes 22, 24–28.
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½Cu2ðL
24Þ2ðSO4ÞðH2OÞ2 (26)
Complex 26 was prepared in a similar fashion to complex 24, using CuSO45H2O. The mixture
was stirred at reflux temperature for 4h, giving a dark-red precipitate.
½CuL24ðNCSÞ  2H2O (27)
For the synthesis of complex 27, the acetate complex was first prepared and the acetate ion was
then displaced by thiocyanate ion by using KSCN (2mmol). Green solid.
½VOðL24Þ2 (28)
Complex 28 was prepared in a similar fashion to complex 24, using VOSO42H2O. Brown solid.
2.3. Antibacterial activity
The complexes and ligandsHL21–24 were tested for their in vitro antibacterial activity against
de Staphylococcus aureus var. Oxford 6538, Klebsiella pneumoniae ATCC 100131, Escherichia coli
ATCC 10536, and Pseudomonas aeruginosa ATCC 9027 strains using the paper disc diffusion
method (for the qualitative determination) and the serial dilutions in liquid broth method
(for determination of MIC) [66]. Streptomycin was used as internal standard.
The results of the antibacterial activity point out the fact that the activity of the Schiff bases
HL21–24 is more pronounced when it coordinates at the metal ion (Table 1). In case of com-
plexes 1, 6, 10, 12, 15, 18, 19, 20, 23, 25, 26, and 28, there can be seen a visible increase in the
antibacterial action.
Missing a clear action mechanism, in vitro, of the respective ligand of the complexes obtained
on a microbian stem, there can be made the following stipulations:
-the structure of the tested complexes seems to be the main element that influences the
antibacterial activity. Thus, for complexes 1, 6, 10, 12, 15, 19, 20, 23, 25, 26, and 28, there has
been determined an increased activity against all bacterial species, probably due to the
presence of the monomeric form in DMSO solution and also due to the tetracoordination of
the metal center.
-the presence of the anions with a large volume, in the outer coordination sphere of the
complexes, can be deemed as another main element that can influence the antibacterial activ-
ity. The complexes 5, 6, 15, 19, 20, and 25 contain the groups ClO4
- and SO4
2-, respectively, and
prevent a visible increase in their activity against all species of bacteria used.
-if there is drawn a comparison between the coefficients of the molecular orbitals, computed on
the basis of the transitions noticed in spectra UV-Vis and of the parameters g and A in spectra
EPR [69] and the antibacterial activity, the conclusion is the fact that, for the complexes with
the most pronounced activity, the values of δ2 parameter to a weak covalent character of the
link pi out of the plan.
Descriptive Inorganic Chemistry Researches of Metal Compounds84
Compusul
Minimum inhibitory concentration (μg/ml)
K. pneumoniae G(+)
S. aureus
G(+)
P. aeruginosa
G()
E. coli
G()
HL21 256 256 512 128
[Cu2(L
21)2(Cl)2] (1) 32 8 32 32
[CuL21(NO3)] (2) 64 32 256 512
[CuL21(OAc)] (3) 64 32 256 512
[CuL21(SCN)] (4) 64 32 256 512
[CuL21(H2O)]ClO4 (5) 32 32 128 256
[Cu2(L
21)2(H2O)4]SO4 (6) 16 8 32 32
[Ni(L21)2] (7) 512 512 256 512
[VO(L21)2] (8) 265 256 64 256
[Mn(L21)2] (9) 256 512 256 128
HL22 128 256 256 512
[Cu(L22)Cl(H2O)] (10) 16 8 128 16
[Cu(L22)(NO3)(H2O)2] (11) 128 128 256 256
[Cu(L22)2 ] (12) 8 4 16 64
[CuL22(SCN)(H2O)2] (13) 64 64 256 512
[CuL22(ClO4)(H2O)2] (14) 256 128 256 512
[Cu2(L
22)2(H2O)4]SO4 (15) 8 16 128 16
HL23 64 128 64 32
[Cu(L23)2Cl2] (16) 64 128 64 64
[Cu(L23)2](NO3)2 (17) 128 64 32 64
[Cu(L23)2(OAc)2] (18) 8 4 16 16
[Cu(L23)2(H2O)2]SO4 (19) 8 8 64 16
[VO(L23)2(H2O)]SO4 (20) 64 128 16 256
[Ni(L23)2(H2O)2]Cl2 (21) 256 256 256 128
HL24 128 256 256 512
[CuL24Cl]2 (22) 64 64 256 512
[CuL24(H2O)2]NO32.25H2O (23) 16 8 128 16
[Cu(L24)(OAc)(H2O)] (24) 128 128 256 256
[CuL24(H2O)2] ClO4 (25) 8 4 16 64
[Cu2(L
24)2(SO4)(H2O)2] (26) 8 64 16 64
[CuL24(NCS)]2H2O (27) 256 128 256 512
[VO(L24)2] (28) 8 16 128 16
Streptomycin 8 4 16 8
K. pneumoniae (Klebsiella pneumoniae ATCC 31488); S. aureus (Staphylococus aureus var. Oxford ATCC 6538); P. aeruginosa
(Pseudomonas aeruginosa ATCC 9027); E. coli (Escherichia coli ATCC 10536). G(): Gram-negative bacteria; G(+): Gram-
positive bacteria.
Table 1. “In vitro” antibacterial activity of the ligands and corresponding complexes.
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3. Conclusion
The investigations of the antibacterial screening, carried out for these new classes of com-
pounds, reveal the fact that they present activity, especially toward the gram-positive bacteria,
in comparison with the standard streptomycin. The increased antibacterial activity of the metal
complexes can be accounted for by a cluster of reasons that refer to the chelation theory, nature
of the ligand and of the metal ion, the geometry of the metal complexes, liposolubility, the
presence of the co-ligands, and a series of sterical and pharmacokinetic factors. We can say
that, ten of the complexes synthetized can be successfully used instead of streptomycin, where
there is resistance to this antibiotic.
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